MediPharm Sinks by Over 14% on Q1 Results
MediPharm Labs (OTC: MEDIF) was not a bright star in the marijuana industry on Thursday. The cannabis-extraction specialist's stock took a nasty hit following the release of Q1 of fiscal 2020 results that morning.
MediPharm recorded some dramatic declines during the period. Revenue fell by nearly 50% on a year-over-year basis to 11.1 million Canadian dollars ($8.2 million). This represented a deeper sequential fall, as the Q4 2019 result was CA$32.4 million ($23.9 million).
Image source: Getty Images.
Source Fool.com
